Aktis Oncology

Aktis Oncology is a pioneering biotechnology company dedicated to realizing the curative power of alpha radiopharmaceuticals for mainstream cancer care. Aktis Oncology is focused on the discovery and development of a new class of targeted radiopharmaceuticals designed to treat a broad range of solid tumor cancers.

Aktis Oncology is committed to innovation and excellence in the field of oncology. Through cutting-edge research and development, Aktis Oncology strives to bring new hope and improved outcomes to patients battling cancer. The company's work is driven by a passion for scientific advancement and a deep understanding of the unmet needs in cancer treatment.

The team at Aktis Oncology is working diligently to advance its pipeline and expand its impact on the future of cancer care. We invite the management team at Aktis Oncology to create a customized and exclusive company showcase and product listing on our platform to highlight your achievements and further enhance your commercial development.